Mathilde J. Richard
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Polymerase trapping as the mechanism of H5 highly pathogenic avian influenza virus genesis.
Journal: Science (New York, N.Y.)
Published: March 12, 2026
Enhanced Human Antigen-Specific B Cell Responses Using In Vitro 3D Tonsil Cultures Containing Stromal Cells.
Journal: Advanced healthcare materials
Published: October 24, 2025
Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals.
Journal: Nature microbiology
Published: August 08, 2025
Characterisation of immune responses targeting highly pathogenic avian influenza A(H5) viruses in health-care workers in the Netherlands: an observational, cross-sectional analysis.
Journal: The Lancet. Microbe
Published: July 22, 2025
Molecular basis of 60 years of antigenic evolution of human influenza A(H3N2) virus neuraminidase.
Journal: Cell host & microbe
Published: June 11, 2025
Evolution, spread and impact of highly pathogenic H5 avian influenza A viruses.
Journal: Nature reviews. Microbiology
Published: April 24, 2025
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 15, 2025
The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
Journal: bioRxiv : the preprint server for biology
Published: January 20, 2025
A vaccine antigen central in influenza A(H5) virus antigenic space confers subtype-wide immunity.
Journal: bioRxiv : the preprint server for biology
Published: November 18, 2024
A vaccine central in A(H5) influenza antigenic space confers broad immunity.
Journal: Nature
Published: October 27, 2024
Last Updated: 09/26/2026